Drug
Tempol clinical trials
- studies test it
- 9
- open now
- 2
- in phase 3
- 1
- first study started
- 2007
Keep track of what changes. Save the tempol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
Matrix Biomed, Inc. (3) · The University of Texas at Arlington (2) · Mitos Pharmaceuticals (2) · University of Georgia (1) · Adamis Pharmaceuticals Corporation (1)
Often tested with
Tested in the same studies.
Acetovanillone (2) · Allopurinol (2) · Tempol-containing MBM-02 (2) · Phenylephrine (1) · Mitoquinone (1) · MitoTEMPO (1) · NG-Nitroarginine Methyl Ester (1)
Studies
Open first, then newest update. How each study uses tempol is read from its arms, and is right about nine times in ten.
Testing it · 9
- Effects of an Antioxidant Supplement on Blood Vessel HealthRecruitingPhase 2University of GeorgiaNCT06424756Written as Tempol
- Treatment of Radiation and Cisplatin Induced Toxicities with TempolRecruitingPhase 2Matrix Biomed, Inc.NCT03480971Written as Tempol
- Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients.TerminatedPhase 2/3Adamis Pharmaceuticals CorporationNCT04729595Written as Tempol
- MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate CancerStatus unknownPhase 2Matrix Biomed, Inc.NCT04876755Written as MBM-02
- MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)Status unknownPhase 2Matrix Biomed, Inc.NCT04874506Written as MBM-02
- The Effect of Local Antioxidant Therapy on Racial Differences in VasoconstrictionCompletedPhase 1The University of Texas at ArlingtonNCT03680404Written as Phenylephrine + Tempol
- The Effect of Antioxidants on Skin Blood Flow During Local HeatingCompletedPhase 1The University of Texas at ArlingtonNCT03680638Written as Tempol
- Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the BrainStatus unknownPhase 2Mitos PharmaceuticalsNCT00801086Written as 7% (w/v) Tempol alcohol-based gel (MTS-01)
- Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain RadiotherapyTerminatedPhase 2Mitos PharmaceuticalsNCT00713154Written as MTS-01
Given in every arm · 1 — tempol is usual care beside what is tested
Codes
What other systems call tempol · ClinicalTrials.gg INT002240
- MeSH (NLM) C001803tempolConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) U78ZX2F65XTEMPOLConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C001803 | tempol | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | U78ZX2F65X | TEMPOL | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.